ES396473A1 - Isoindorinjudotaino seiho - Google Patents

Isoindorinjudotaino seiho

Info

Publication number
ES396473A1
ES396473A1 ES396473A ES396473A ES396473A1 ES 396473 A1 ES396473 A1 ES 396473A1 ES 396473 A ES396473 A ES 396473A ES 396473 A ES396473 A ES 396473A ES 396473 A1 ES396473 A1 ES 396473A1
Authority
ES
Spain
Prior art keywords
formula
general formula
hydrogen
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES396473A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of ES396473A1 publication Critical patent/ES396473A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedure for the preparation of isoindoline derivatives of the general formula **(See formula)** where R is a member selected from the group consisting of hydrogen and lower alkyl of 1 to 4 carbon atoms, and R1 is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 4 carbon atoms and a group of the general formula (see formula), where, n is 1 or 2 and R1 and R3 are independently selected from the group consisting of hydrogen and lower alkyl of 1 to 4 carbon atoms, and physiologically acceptable basic addition salts of compounds of the general formula (i) where R1 is hydrogen, as well as physiologically acceptable acid addition salts of compounds of the general formula where R1 is the group **(See formula)** a) react o-cyano-benzyl bromide **(See formula)** with a compound of the general formula **(See formula)** where X is a carbalkoxy or a cyano group or a carboxyl group, and R has the above significance, to form a compound of the general formula **(See formula)** where R and X have the above significance, which is subsequently reacted with appropriate bases or with appropriate acids, to give compounds of the general formula (I), where R1 is hydrogen and subsequently, if desired, esterify the compounds of the general formula (I), where it is hydrogen, thus obtained, or b) reacting phthalide **(See formula)** with a compound of the general formula (II), where X is a carbalkoxy group or a cyano group thus obtaining a compound of the formula **(See formula)** where X and R have the above significance, which, if desired, is subsequently reacted by saponification with appropriate bases or with appropriate acids, to give compounds of the general formula (I), where R1 is hydrogen, and subsequently, if desired, esterify the compounds of the general formula (I), where R1 is hydrogen thus obtained, or (c) react thiophthalide **(See formula)** with a compound of the formula (II) where X is a carbalkoxy group or a cyano group, thus obtaining a compound of the formula (IV) which, if desired, is subsequently reacted by saponification to give compounds of the general formula (I), where R1 is hydrogen, which, if desired, is esterified as described in process (a); or (d) react Italic aldehyde **(See formula)** with a compound of the formula (II), where X is a carbalkoxy group or a cyano group, thereby obtaining a compound of the formula (IV) which, if desired, is subsequently reacted by saponification to give compounds of the general formula (I), where R1 is hydrogen, which if desired is esterified as described in process (a); or (e) react italic anhydride **(See formula)** with a compound of the formula (II), where X is a carbalkoxy group or a cyano group, thus obtaining compounds of the formula **(See formula)** where X and R have the above significance, which is subsequently reduced with an appropriate reducing agent, to give a compound of formula (IV), which is subsequently, if desired, reacted by saponification to give compounds of general formula (I), where R1 is hydrogen, which, if desired, is esterified as described in process (a); or (f) reacting compounds of the general formula **(See formula)** where the groups R4 are both hydrogen, both methyl groups or both ethyl groups, with a compound of the formula (II), where X is a carbalkoxy group or a cyano group, thus obtaining a compound of the formula (V), where X and R have the above significance, which is subsequently reduced to give a compound of formula (IV), which is then, if desired, saponified to give compounds of general formula (I), wherein R1 is hydrogen, which, if desired, is esterified as described in process (a); and, if desired, the compounds of the general formula (I), where R1 is hydrogen, are reacted with an appropriate base to give a physiologically acceptable salt, or the compounds of the general formula (I) are reacted, where R1 is the group (see formula), with an appropriate acid to give a physiologically acceptable salt. (Machine-translation by Google Translate, not legally binding)
ES396473A 1970-11-05 1971-10-28 Isoindorinjudotaino seiho Expired ES396473A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT3133470 1970-11-05
IT3151470 1970-11-10

Publications (1)

Publication Number Publication Date
ES396473A1 true ES396473A1 (en) 1974-05-16

Family

ID=26328923

Family Applications (1)

Application Number Title Priority Date Filing Date
ES396473A Expired ES396473A1 (en) 1970-11-05 1971-10-28 Isoindorinjudotaino seiho

Country Status (18)

Country Link
JP (6) JPS5111627B1 (en)
AT (1) AT313894B (en)
BE (1) BE774985A (en)
CA (1) CA978973A (en)
CH (4) CH559176A5 (en)
DD (1) DD95379A5 (en)
DK (1) DK154761C (en)
ES (1) ES396473A1 (en)
FI (1) FI54294C (en)
FR (1) FR2112480A1 (en)
HU (1) HU164391B (en)
IE (1) IE35767B1 (en)
IL (1) IL38023A (en)
MY (1) MY7400288A (en)
NL (1) NL170283C (en)
NO (1) NO135785C (en)
SE (1) SE374917B (en)
YU (1) YU34984B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154525A1 (en) * 1970-11-05 1972-06-15 Carlo Erba S.P.A., Mailand (Italien) Isoindoline derivatives and processes for their preparation
DE2755345A1 (en) * 1977-04-05 1978-10-19 Grelan Pharmaceutical Co 2-OXO-PHENYLBUTTERIC ACID DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PREPARATIONS CONTAINING THESE COMPOUNDS
JPS53145735U (en) * 1977-04-23 1978-11-16
JPS545333U (en) * 1977-06-15 1979-01-13
JPS5416115U (en) * 1977-07-01 1979-02-01
JPS5424235U (en) * 1977-07-20 1979-02-17
JPS6210796Y2 (en) * 1979-06-01 1987-03-13
US5480362A (en) * 1992-09-03 1996-01-02 Honda Giken Kogyo Kabushiki Kaisha Double planetary carrier
CN1302881C (en) * 2004-12-10 2007-03-07 华东理工大学 Method and apparatus for preparing superfine powder by super high pressure supercritical fluid micro jetting technology

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2034240C2 (en) * 1968-03-27 1982-12-02 CIBA-GEIGY AG, 4002 Basel Isoindoline derivatives, processes for the preparation of these compounds and their use
JPS5035076A (en) * 1973-08-01 1975-04-03

Also Published As

Publication number Publication date
BE774985A (en) 1972-05-05
DK154761C (en) 1989-06-12
JPS5429491B2 (en) 1979-09-25
DD95379A5 (en) 1973-02-05
HU164391B (en) 1974-02-28
FR2112480B1 (en) 1975-08-01
IE35767L (en) 1972-05-05
IL38023A0 (en) 1971-12-29
JPS5231065A (en) 1977-03-09
JPS5231066A (en) 1977-03-09
JPS5217463A (en) 1977-02-09
IE35767B1 (en) 1976-05-12
CH559176A5 (en) 1975-02-28
JPS54117464A (en) 1979-09-12
NL170283C (en) 1982-10-18
JPS6019748B2 (en) 1985-05-17
JPS5434726B2 (en) 1979-10-29
DK154761B (en) 1988-12-19
CH559174A5 (en) 1975-02-28
CA978973A (en) 1975-12-02
AT313894B (en) 1974-03-11
JPS5111627B1 (en) 1976-04-13
SE374917B (en) 1975-03-24
NL170283B (en) 1982-05-17
FI54294C (en) 1978-11-10
CH559175A5 (en) 1975-02-28
YU34984B (en) 1980-06-30
YU275671A (en) 1979-12-31
NO135785C (en) 1977-06-01
JPS5429492B2 (en) 1979-09-25
NO135785B (en) 1977-02-21
CH558353A (en) 1975-01-31
FR2112480A1 (en) 1972-06-16
JPS5168563A (en) 1976-06-14
NL7115288A (en) 1972-05-09
MY7400288A (en) 1974-12-31
FI54294B (en) 1978-07-31
IL38023A (en) 1974-12-31

Similar Documents

Publication Publication Date Title
ES411052A1 (en) Disperse azo dyestuffs
ES396473A1 (en) Isoindorinjudotaino seiho
ES398036A1 (en) T2-phosphonobutane 1,2,4-tricarboxylic acid compounds process for their preparation and their use as complex formers
ES381579A1 (en) Hexahydro-fluoren-2-yloxy alkanoic acids and esters thereof
ES405648A1 (en) Procedure for the preparation of new acids 4- (4 bifenilil) -4-hydroxy-butirrics, its esteres or lactonas. (Machine-translation by Google Translate, not legally binding)
ES421098A1 (en) Fluoro-substituted thiaxanthene derivatives
ES449817A1 (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
ES379619A1 (en) A process for the manufacture of amino acids and derivatives thereof
ES431724A1 (en) Erythrodiol derivatives
ES438695A1 (en) A procedure for the preparation of prostate acid derivatives. (Machine-translation by Google Translate, not legally binding)
ES406124A1 (en) Procedure for the preparation of acids 4- (4-bifenilil) -butirrics and their steres. (Machine-translation by Google Translate, not legally binding)
ES444634A2 (en) Procedure for the preparation of derivatives of isoindoline. (Machine-translation by Google Translate, not legally binding)
ES446239A1 (en) 8-azaprostaglandins and process for the preparation thereof
ES366533A1 (en) 1,2-oxazinyl phenyl alkanoic acids
ES325387A1 (en) Procedure for preparing insatured carboxylic acids. (Machine-translation by Google Translate, not legally binding)
ES420666A1 (en) (1-methyl-5-nitro-2-imidazolyl)thioalkanoic acids and derivatives
ES426949A1 (en) Procedure for the preparation of new 1,4-benzodiazepinas. (Machine-translation by Google Translate, not legally binding)
ES377995A1 (en) Procedure for the preparation of new derivatives of imidazolidinone. (Machine-translation by Google Translate, not legally binding)
ES384598A1 (en) Procedure for the preparation of new basic pirrol derivatives. (Machine-translation by Google Translate, not legally binding)
ES383106A1 (en) Procedure for the preparation of new derivatives of dibenzociclopropapenteen. (Machine-translation by Google Translate, not legally binding)
ES406885A1 (en) Procedure for producing N-halogenoacilanilino fatty acids and their ester derivatives. (Machine-translation by Google Translate, not legally binding)
ES411184A1 (en) Alpha-carboxy-2-thienylmethylpenicillin and cephalosporin and esters and salts thereof
ES450472A1 (en) Benzoyl pyrazole 5-acetic acid derivatives useful as uricosurucs
ES382611A1 (en) Procedure for the preparation of new derivatives of imidazolidinone. (Machine-translation by Google Translate, not legally binding)
ES400725A1 (en) A procedure for the obtaining of derivatives of s-triazo - (4,3, -a) -piridine. (Machine-translation by Google Translate, not legally binding)